| ¿µ¹® | secretion | ÇÑ±Û | ºÐºñ, ºÐºñ¹° |
|---|---|---|---|
| ¼³¸í | ƯÀÌÇÑ »ý»ê¹°À» ¸¸µé¾î ¼¼Æ÷ ¹ÛÀ¸·Î ³»º¸³»´Â ¼¼Æ÷ÀÇ È°µ¿ ¶Ç´Â ±× »ý»ê¹°À» ¸»ÇÑ´Ù. ¿¹¸¦ µé¾î ÀÌÀÚ¼¼Æ÷´Â ¼ÒÈÈ¿¼ÒÀÎ ÀÌÀÚ¾×À» ¸¸µé¾î ºÐºñÇÏ´Â µ¥, ÀÌ ¶§ ÀÌÀÚ¾×À» ºÐºñ¹°À̶ó ÇÔ. |
||
| ¿µ¹® | basal metabolic rate(BMR) | ÇÑ±Û | ±âÃÊ´ë»çÀ² |
|---|---|---|---|
| ¼³¸í | Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸ÀÌ´Â ÆíÂ÷¸¦ Ç¥½ÃÇÏ´Â Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°ÀÎÀÇ ±âÃÊ´ë»ç·®Àº üǥ¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» üǥ¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. üǥ¸éÀûÀº ½ÅÀå°ú üÁß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êÈź¼Ò ¹ß»ý·®¿¡¼ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀÌ¸é ±âÃÊ´ë»çÇ×Áø, £10% ÀÌÇÏÀÌ¸é ±âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù. |
||
| ¿µ¹® | five-year survival rate | ÇÑ±Û | ¿À³â»ýÁ¸À² |
|---|---|---|---|
| ¼³¸í | 1. µ¿ÀÏ Áúº´ÀÇ Áø´Ü ȤÀº Ä¡·á ÈÄ, 5³âÀÌ °æ°ú µÈ µÚÀÇ »ýÁ¸ÀÚ¼öÀÇ Ç¥Çö. 2. ¾ÏÀÇ Áø´Ü ¶Ç´Â Ä¡·á µÚ¿¡ °Ë»ç¸¦ ¹Ýº¹ÇÏ¿© 5³â µ¿¾È »ì¾Æ ÀÖ´Â »ç¶÷ÀÇ ¹éºÐÀ². Ä¡·á ÈÄ 5³â µ¿¾È »ýÁ¸Çϸé ÀÏ´Ü Ä¡À¯µÈ °ÍÀ¸·Î °£ÁÖÇÑ´Ù. |
||
| ¿µ¹® | ESR(Erythrocyte Sedimentation Rate) | ÇÑ±Û | ÀûÇ÷±¸Ä§°¼Óµµ, Ç÷ħ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÀÌ ÀÀ°íµÇ´Â °ÍÀ» ¹æÁöÇÏ´Â Ç×ÀÀ°íÁ¦¸¦ ³ÖÀº Ç÷¾×À» ħ°¿ë À¯¸®°ü¿¡ ³Ö¾î °¡¸¸È÷ ¼¼¿ö µÎ¾úÀ» ¶§ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â ¼Óµµ¸¦ À̸£´Â ¸»ÀÌ´Ù. 1918³â ½º¿þµ§ÀÇ º´¸®ÇÐÀÚ ÆÄ·¹¿ì½ºÀÇ Ã¢¾È¿¡ ÀÇÇÑ °ÍÀÌ´Ù. ÃøÁ¤¹æ¹ýÀ¸·Î ¿©·¯ °¡Áö°¡ Àִµ¥, ±¹Á¦Ç¥ÁعýÀ¸·Î´Â 1973³â ¿þ½ºÅͱ׷»¹ýÀÇ 1½Ã°£¹ýÀÌ ¼±Á¤µÇ¾úÀ¸¸ç, 1977³â ±×°ÍÀ» °³Á¤ÇÏ¿© °¢±¹¿¡¼ ¾²µµ·Ï ±ÇÀåÇϰí ÀÖ´Ù. 1½Ã°£ ÈÄ Ä§°¿ë À¯¸®°ü À§ÂÊÀÇ Ç÷Àå±âµÕÀÇ ³ôÀ̸¦ mm·Î Àоî, ±×°ÍÀ» ÀûÇ÷±¸Ä§°ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ¸¸¾à Ç÷Àå°ú ÀûÇ÷±¸ÀÇ °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ °æ¿ì, ÀûÇ÷±¸ÀÇ ¹Ðµµ°¡ ±× ÀÌÇÏ¿¡¼´Â ÀÏÁ¤ÇÏ´Ù°í ¿©°ÜÁö´Â °÷ÀÇ ´«±ÝÀ» Àоî ÀûÇ÷±¸Ä§°ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ÃøÁ¤ ¶§ÀÇ ½Ç³»¿Âµµ´Â 18~25µµ·Î ÇÑ´Ù. ÀϹÝÀûÀ¸·Î À̺¸´Ù ¿Âµµ°¡ ³ôÀº °æ¿ì´Â Ç÷ħ¹ÝÀÀÀÌ ÃËÁøµÇ¸ç, ³·Àº °æ¿ì´Â ´Ê¾îÁø´Ù. Á¤»ó °ªÀº 2~10mm(³²ÀÚ), 3~15mm(¿©ÀÚ)À̸ç 15¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ, 50¼¼ ÀÌ»óÀÇ °í·ÉÀÚ¿¡¼´Â ¾à°£ ³ô´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
| CSR | central supply room; chart-stimulated recall [test]; Cheyne-Stokes respiration; continued stay revie... |
| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
| CPR | cardiopulmonary reserve; cardiopulmonary resuscitation; centripetal rub; cerebral cortex perfusion r... |
| ASR | Aldosterone Secretion Rate |
|---|---|
| ISR | Insulin secretion rate |
| RSR | Renin secretion rate |
| SR | Secretion Rate |
| CVS | Cervicovaginal secretion |
| glands of internal secretion | Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. (12 Dec 1998) |
|---|---|
| cytocrine secretion | The transfer of secretory material from one cell to another, such as the transfer of melanin granules from melanocytes to epidermal cells. (05 Mar 2000) |
| secretion | 1. <physiology> The process of elaborating a specific product as a result of the activity of a gland, this activity may range from separating a specific substance of the blood to the elaboration of a new chemical substance. 2. Any substance produced by secretion. Origin: L. Secretio, from secernere = to secrete (09 Oct 1997) |
| secretion vector | <molecular biology> A DNA vector in which the protein product is both expressed and secreted (excreted) from the cell. (09 Oct 1997) |
| stimulus secretion coupling | A term used to describe the events that link receipt of a stimulus with the release of materials from membrane bounded vesicles (the analogy is with excitation contraction coupling in the control of muscle contraction). A classical example is the link between membrane depolarisation at the presynaptic terminal and the release of neurotransmitter into the synaptic cleft. (18 Nov 1997) |
| neurohumoral secretion | Transmission of a nerve impulse across a synapse or to an end-organ by secretion of a minute amount of a chemical transmitter such as acetylcholine. (05 Mar 2000) |
| syndrome of inappropriate secretion of antidiuretic hormone | Continued secretion of antidiuretic hormone despite low serum osmolality and expanded extracellular volume. (05 Mar 2000) |
| external secretion | A substance formed by a cell and transported outside the cell walls as a means of ridding the cell of the substance or as a messenger to affect the function of other cells. (05 Mar 2000) |
| acute tubular necrosis | <nephrology> A kidney disorder that results in damage to the renal tubule cells leading to acute renal failure. Acute tubular necrosis can result from any condition which deprives the kidney of oxygen (ischaemia). Acute tubular necrosis may occur as a complication of shock, trauma or sepsis. Conditions such as diabetes or liver disease can predispose people to the development of acute tubular necrosis. Certain medications (for example aminoglycosides, amphotericin B, cyclosporine) are known to cause acute tubular necrosis as a toxic side effect. Radiopaque contrast dyes, used in some radiologic procedures, may also result in acute tubular necrosis as a rare complication from contrast dye use. Acronym: ATN (13 Nov 1997) |
| renal tubular acidosis | <nephrology> A rare sometimes familial disorder of the renal tubule characterised by the inability to excrete urine of normal acidity. This leads to a hyperchloraemic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion. (25 Jun 1999) |
| renal tubular transport, inborn errors | Genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of henle function, and distal nephron function. The transport defects can be selective or nonselective. (12 Dec 1998) |
| Pick's tubular adenoma | A neoplasm of the ovary, arising from the ovarian stroma, mimicking to a greater or lesser extent derivatives of the sex cord mesenchyme of the testis, and sometimes causing defeminization and virilization. (12 Dec 1998) |
| primary renal tubular acidosis | A metabolic defect in the mechanism of urinary acidification that may be either the transient type, with onset in infancy, or the persistent type, with onset in childhood or adult years; both types are familial. (05 Mar 2000) |
| secondary renal tubular acidosis | Renal tubular acidosis that may occur as a complication of hypercalcaemic states, hyperglobulinaemic disorders, and in some other chronic renal conditions; a regular component of De Toni-Fanconi syndrome. (05 Mar 2000) |
| osteopetrosis with renal tubular acidosis | <syndrome> An inherited deficiency of carbonic anhydrase II that results in osteopetrosis and metabolic acidosis. Synonym: osteopetrosis with renal tubular acidosis. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|